Accessible version InnoScience Technology Global GaN power semi leader, well- positioned for rapid growth; initiate at Buy Initiating Coverage: BUY | PO: 108.00 HKD | Price: 74.40 HKD Initiate at Buy, PO of HK$108 (45% upside potential) We initiate coverage on InnoScience at Buy with a PO of HK$108. InnoScience is a Gallium Nitride (GaN) power semiconductor leader with largest market share of 30% (by revenue) globally in 2024. We are positive on its long-term growth outlook, given (1) rapid growth of global ...

每经AI快讯，英诺赛科(02577.HK)涨超5%，截至发稿，涨3.55%，报75.9港元，成交额1.06亿港元。 ...

Core Viewpoint - InnoLux (02577) is recognized as a leading player in the GaN power semiconductor market, holding a 30% global market share in revenue last year, with a strong long-term growth outlook driven by a rapidly expanding market and strategic partnerships [1] Company Summary - InnoLux's stock rose over 5%, currently trading at 75.9 HKD with a transaction volume of 106 million HKD [1] - Bank of America Securities initiated coverage with a "Buy" rating and a target price of 108 HKD [1] - The forecasted revenue compound annual growth rate (CAGR) for InnoLux from 2024 to 2027 is 72% [1] Industry Summary - The global GaN power semiconductor market is expected to grow at a CAGR of 63% from 2024 to 2028 [1] - InnoLux's profitability is anticipated to improve due to economies of scale and technological innovations [1] - A collaboration with NVIDIA to develop an 800V HVDC architecture is expected to enhance revenue potential starting in 2027 [1]

Group 1 - The core viewpoint of the article highlights that InnoLux (02577) is a leading company in the GaN power semiconductor market, with a global market share of 30% based on revenue last year [1] - Bank of America Securities has initiated coverage on InnoLux with a "Buy" rating and a target price of HKD 108, indicating strong confidence in the company's growth potential [1] - The global GaN power semiconductor market is expected to grow at a compound annual growth rate (CAGR) of 63% from 2024 to 2028, which supports the long-term growth outlook for InnoLux [1] Group 2 - InnoLux is expected to benefit from economies of scale and technological innovations that will continuously improve its profitability [1] - The collaboration with NVIDIA to develop an 800V HVDC architecture is anticipated to enhance revenue potential starting in 2027 [1] - Revenue growth for InnoLux is projected to have a CAGR of 72% from 2024 to 2027, with a forecasted net profit margin of 12.1% in 2027, while 2024 is expected to show a negative net profit margin of 126.2% [1]

Core Viewpoint - Bank of America Securities initiates coverage on Innoscience Technology (02577) with a "Buy" rating and a target price of HKD 108, highlighting its leadership in the GaN power semiconductor market with a 30% global market share by revenue last year [1] Group 1: Company Overview - Innoscience Technology is recognized as a leading company in the GaN power semiconductor sector [1] - The company achieved a global market share of 30% in the GaN power semiconductor market last year [1] Group 2: Market Growth Potential - The global GaN power semiconductor market is expected to grow at a compound annual growth rate (CAGR) of 63% from 2024 to 2028 [1] - Bank of America Securities forecasts a revenue CAGR of 72% for Innoscience Technology from 2024 to 2027 [1] Group 3: Profitability and Collaborations - Scale economies and technological innovations are anticipated to continuously improve profitability for Innoscience Technology [1] - The collaboration with NVIDIA to develop an 800V HVDC architecture is expected to enhance revenue potential starting in 2027 [1] - The projected net profit margin for Innoscience Technology in 2027 is estimated to be 12.1% [1]

Core Viewpoint - Bank of America Securities initiates coverage on Innoscience Technology (02577) with a "Buy" rating and a target price of HKD 108 [1] Company Summary - Innoscience Technology is a leading player in the gallium nitride (GaN) power semiconductor market, holding a 30% global market share by revenue last year [1] - The company is expected to benefit from a partnership with NVIDIA to develop an 800V HVDC architecture, which is projected to enhance revenue potential starting in 2027 [1] Industry Summary - The global GaN power semiconductor market is anticipated to grow at a robust compound annual growth rate (CAGR) of 63% from 2024 to 2028 [1] - Bank of America forecasts a compound annual growth rate of 72% for Innoscience's revenue from 2024 to 2027, with a projected net profit margin of 12.1% by 2027 [1]

美银证券发表报告，首次覆盖英诺赛科，予"买入"评级，目标价108港元。该行指，看好英诺赛科长期 增长前景，原因包括全球GaN功率半导体市场以63%的年均复合增长率快速增长(2024至2028年)；规模 经济和技术创新令盈利能力持续改善；及与英伟达合作开发800V HVDC 架构，自2027年起带来收入上 升潜力。美银证券预测英诺赛科2024至2027年收入年复合增长率为72%，2027年的净利润率料为 12.1%。 ...

Core Points - InnoCare Pharma (02577) announced that on November 5, 2025, the trustee of the 2025 Share Award Plan purchased a total of 239,000 H shares from the market [1] Group 1 - The shares purchased will be held in trust for the benefit of eligible participants [1]

Core Viewpoint - InnoCare Pharma (02577) announced that on November 5, 2025, the trustee of the 2025 Share Award Plan purchased a total of 239,000 H-shares from the market, which will be held in trust for the benefit of eligible participants [1] Group 1 - The company has initiated a share award plan aimed at incentivizing eligible participants [1] - The total number of H-shares purchased under this plan is 239,000 [1] - The shares are held in trust, indicating a structured approach to employee compensation [1]

格隆汇11月5日丨英诺赛科(02577.HK)公告，内容有关公司采纳的2025年股份奖励计划。于2025年11月5 日，该计划的受托人("受托人")已根据该计划的条款及条件，从市场合共购买公司23.9万股H股，并为合 资格参与者(定义见该计划)的利益以信托形式持有该等股份。 ...